Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Eisai Inc.
Sort By
Newest First
1 / 1
Appointment
Eisai Inc. Deepens Its Commitment to Alzheimer's Disease with Key Executive Appointments
Eisai
PR-M05-19-NI-015
May 06, 2019
Alzheimer's Disease
First Drug Candidate From Eisai-UCL Research Collaboration To Enter Alzheimer's Disease Clinical Trials
Eisai
PR-M12-18-NI-037
Dec 12, 2018
Epilepsy
New Analyses Evaluate Long-Term Convulsive Seizure Freedom Rates With Use Of Adjunctive FYCOMPA® (perampanel) CIII In Adult Patients Presented at Annual Meeting of the AES
Eisai
PR-M12-18-NI-015
Dec 05, 2018
Clinical Data
Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®
Eisai
PR-M07-18-NI-056
Jul 18, 2018
1 / 1
